The Current Ratio as of December 2025 (TTM) for NeoCore Technology Co., Ltd. (4131.TWO) is 1.59

According to NeoCore Technology Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.59. This represents a change of -72.40% compared to the average of 5.75 of the last 4 quarters.

NeoCore Technology Co., Ltd. (4131.TWO) Historical Current Ratio (quarterly & annually)

How has 4131.TWO Current Ratio performed in the past?

The mean historical Current Ratio of NeoCore Technology Co., Ltd. over the last ten years is 3.94. The current 1.59 Current Ratio has changed 3.93% with respect to the historical average. Over the past ten years (40 quarters), 4131.TWO's Current Ratio was at its highest in in the December 2024 quarter at 17.08. The Current Ratio was at its lowest in in the September 2022 quarter at 0.97.

NeoCore Technology Co., Ltd. (4131.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NeoCore Technology Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeoCore Technology Co., Ltd. (4131.TWO) Average Current Ratio

How has 4131.TWO Current Ratio performed in the past?

The current Current Ratio of NeoCore Technology Co., Ltd. (4131.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NeoCore Technology Co., Ltd. (4131.TWO) Current Ratio vs. Peers

How is 4131.TWO’s Current Ratio compared to its peers?

NeoCore Technology Co., Ltd.’s Current Ratio is less than MegaPro Biomedical Co., Ltd (4.34), less than LabTurbo Biotech Corporation (14.89), greater than Taiwan Advance Bio-Pharmaceutical Inc. (0.90), less than GeneReach Biotechnology Corp. (2.23), greater than Lukas Biomedical Inc. (1.21), less than Bio Preventive Medicine Corp. (19.06), less than Great Novel Therapeutics Biotech & Medicals (30.32), less than Neith Corporation (15.65), less than Level Biotechnology Inc. (1.63), less than LAUNXP Biomedical Co., Ltd (7.53),

Build a custom stock screener for NeoCore Technology Co., Ltd. (4131.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoCore Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeoCore Technology Co., Ltd. (4131.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeoCore Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.